Cargando…

New perspectives on targeted therapy in ovarian cancer

Epithelial ovarian cancer remains the most lethal gynecologic malignancy. During the last 15 years, there has been only marginal improvement in 5 year overall survival. These daunting statistics are compounded by the fact that despite all subtypes exhibiting striking heterogeneity, their systemic ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coward, Jermaine IG, Middleton, Kathryn, Murphy, Felicity
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324539/ https://www.ncbi.nlm.nih.gov/pubmed/25678824 http://dx.doi.org/10.2147/IJWH.S52379

Ejemplares similares

Microbiome-derived metabolome as a potential predictor of response to cancer immunotherapy
por: Malczewski, Agnieszka Beata, et al.
Publicado: (2020)

Size Does Matter: Why Polyploid Tumor Cells are Critical Drug Targets in the War on Cancer
por: Coward, Jermaine, et al.
Publicado: (2014)

A Retrospective Cross-Sectional Cohort Trial Assessing the Prevalence of MTHFR Polymorphisms and the Influence of Diet on Platinum Resistance in Ovarian Cancer Patients
por: Phillips-Chavez, Caitlin, et al.
Publicado: (2021)

Ferroptosis: A New Promising Target for Ovarian Cancer Therapy
por: Zhao, Hongjiang, et al.
Publicado: (2022)

Enhancing Checkpoint Inhibitor Therapy in Solid Tissue Cancers: The Role of Diet, the Microbiome & Microbiome-Derived Metabolites
por: Malczewski, Agnieszka Beata, et al.
Publicado: (2021)

Ovarian Cancer Stem Cells: A New Target for Cancer Therapy
por: Zhan, Qinglei, et al.
Publicado: (2013)

Targeted Therapy in Ovarian Cancer
por: Willmott, Lyndsay J., et al.
Publicado: (2010)

New perspectives on molecular targeted therapy in ovarian clear cell carcinoma
por: Tan, D S P, et al.
Publicado: (2013)

Targeted Therapies in Epithelial Ovarian Cancer
por: Dean, Emma, et al.
Publicado: (2010)

Ovarian Cancer: Biomarkers and Targeted Therapy
por: Radu, Mihaela Raluca, et al.
Publicado: (2021)

Triple-negative breast cancer: new perspectives for targeted therapies
por: Tomao, Federica, et al.
Publicado: (2015)

Ovarian Cancer: Opportunity for Targeted Therapy
por: Tagawa, Tomoko, et al.
Publicado: (2012)

Targeted Therapies in Epithelial Ovarian Cancer
por: Barrena Medel, Nicanor I., et al.
Publicado: (2010)

Ovarian cancer stem cells and targeted therapy
por: Keyvani, Vahideh, et al.
Publicado: (2019)

Ovarian cancer: new developments in clear cell carcinoma and hopes for targeted therapy
por: Yamashita, Yoriko
Publicado: (2015)

Maximum Tolerated Dose and Anti-Tumor Activity of Intraperitoneal Cantrixil (TRX-E-002-1) in Patients with Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer: Phase I Study Results
por: Coward, Jermaine I., et al.
Publicado: (2021)

Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer
por: Pchejetski, Dmitri, et al.
Publicado: (2015)

Targeting the EGF Receptor for Ovarian Cancer Therapy
por: Zeineldin, Reema, et al.
Publicado: (2010)

Ovarian cancer: emerging molecular-targeted therapies
por: Sourbier, Carole
Publicado: (2012)

New Targeted Therapies and Combinations of Treatments for Cervical, Endometrial, and Ovarian Cancers: A Year in Review
por: Gheorghe, Adelina Silvana, et al.
Publicado: (2022)

PTTG: an important target gene for ovarian cancer therapy
por: Panguluri, Siva Kumar, et al.
Publicado: (2008)

Imaging and therapy of ovarian cancer: clinical application of nanoparticles and future perspectives
por: Di Lorenzo, Giovanni, et al.
Publicado: (2018)

Maintenance therapy for recurrent epithelial ovarian cancer: current therapies and future perspectives – a review
por: Gupta, Sudeep, et al.
Publicado: (2019)

Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer
por: Muñoz-Galván, Sandra, et al.
Publicado: (2020)

Front-Line Maintenance Therapy in Advanced Ovarian Cancer—Current Advances and Perspectives
por: Reverdy, Thibaut, et al.
Publicado: (2020)

Targeted Therapy of Uveal Melanoma: Recent Failures and New Perspectives
por: Croce, Michela, et al.
Publicado: (2019)

Bipolar Tumor-Associated Macrophages in Ovarian Cancer as Targets for Therapy
por: Gupta, Vijayalaxmi, et al.
Publicado: (2018)

Calcium signals and potential therapy targets in ovarian cancer (Review)
por: Deng, Fengying, et al.
Publicado: (2023)

Targeting endoplasmic reticulum stress signaling in ovarian cancer therapy
por: Yan, Tianqing, et al.
Publicado: (2023)

Therapeutic targets and new directions for antibodies developed for ovarian cancer
por: Bax, Heather J., et al.
Publicado: (2016)

New Insights into Ferroptosis Initiating Therapies (FIT) by Targeting the Rewired Lipid Metabolism in Ovarian Cancer Peritoneal Metastases
por: Zhan, Shijie, et al.
Publicado: (2022)

Targeted therapy of ovarian cancer including immune check point inhibitor
por: Kim, Jin Young, et al.
Publicado: (2017)

Estrogen Signaling and Its Potential as a Target for Therapy in Ovarian Cancer
por: Langdon, Simon P., et al.
Publicado: (2020)

Leukotrienes in Atherosclerosis: New Target Insights and Future Therapy Perspectives
por: Riccioni, Graziano, et al.
Publicado: (2009)

Targeting ovarian cancer stem cells: a new way out
por: Ma, Huiying, et al.
Publicado: (2023)

Phenolic Acids-Mediated Regulation of Molecular Targets in Ovarian Cancer: Current Understanding and Future Perspectives
por: Nazam, Nazia, et al.
Publicado: (2023)

The target therapy of ovarian clear cell carcinoma
por: Jin, Ying, et al.
Publicado: (2014)

Epigenetics in ovarian cancer: premise, properties, and perspectives
por: Yang, Qilian, et al.
Publicado: (2018)

Neoadjuvant treatment in ovarian cancer: New perspectives, new challenges
por: Nikolaidi, Adamantia, et al.
Publicado: (2022)

Ovarian Cancer: Can Proteomics Give New Insights for Therapy and Diagnosis?
por: Toss, Angela, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8lu5177cmmk5liu6sqqaap6sic